2min chapter

The HemOnc Pulse cover image

What Is the Cost-Effectiveness of Pola-R-CHP in DLBCL?

The HemOnc Pulse

CHAPTER

The Cost Effectiveness of a Novel Therapy for Lymphoma

Dr. Nikhil Firovengadam is a gastroenterologist and therapeutic endoscopist who primarily focuses clinically on pancreatic laryoninoscopy. Dr. Swehta works as an assistant professor at City of Hope in the lymphoma division. The project was to model a regimen that was novel and potentially would change the primary regimen used to treat DLBCL.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode